SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-22-009385
Filing Date
2022-07-29
Accepted
2022-07-29 18:30:44
Documents
1
Period of Report
2022-07-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-56752.html 4  
1 PRIMARY DOCUMENT marketforms-56752.xml 4 3963
  Complete submission text file 0001214659-22-009385.txt   5473
Mailing Address ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address
MORRIS TIMOTHY E (Reporting) CIK: 0001191286 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 221122259

Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Issuer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations